This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2002 Apr 11;346(15):1145-51.

doi: 10.1056/NEJMcp011773.

Clinical practice. Nephropathy in patients with type 2 diabetes

Giuseppe Remuzzi¹, Arrigo Schieppati, Piero Ruggenenti

Affiliations

PMID: 11948275
DOI: 10.1056/NEJMcp011773

Review

Clinical practice. Nephropathy in patients with type 2 diabetes

Giuseppe Remuzzi et al. N Engl J Med. 2002.

. 2002 Apr 11;346(15):1145-51.

doi: 10.1056/NEJMcp011773.

Authors

Giuseppe Remuzzi¹, Arrigo Schieppati, Piero Ruggenenti

Affiliation

¹ Unit of Nephrology, Ospedali Riuniti di Bergamo, Italy.

PMID: 11948275
DOI: 10.1056/NEJMcp011773

No abstract available

PubMed Disclaimer

Comment in

Diabetic nephropathy.
Goto A. Goto A. N Engl J Med. 2002 Sep 19;347(12):947-8; author reply 947-8. doi: 10.1056/NEJM200209193471218. N Engl J Med. 2002. PMID: 12239270 No abstract available.
Diabetic nephropathy.
Brensing KA, Raab P, Frotscher U. Brensing KA, et al. N Engl J Med. 2002 Sep 19;347(12):947-8; author reply 947-8. N Engl J Med. 2002. PMID: 12240691 No abstract available.

Similar articles

Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB, Britton ML. Hughes DB, et al. Pharmacotherapy. 2005 Nov;25(11):1602-20. doi: 10.1592/phco.2005.25.11.1602. Pharmacotherapy. 2005. PMID: 16232022 Review.
[Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control].
Shionoiri H, Yasuda G, Takizawa T, Shionoiri F. Shionoiri H, et al. Nihon Rinsho. 2005 Jun;63 Suppl 6:394-9. Nihon Rinsho. 2005. PMID: 15999741 Review. Japanese. No abstract available.
[Hypertension and diabetic nephropathy, a dangerous duo].
Hausberg M, Hohage H, Kosch M. Hausberg M, et al. Med Klin (Munich). 2005 Nov 15;100(11):729-37; quiz 738-9. doi: 10.1007/s00063-005-1103-4. Med Klin (Munich). 2005. PMID: 16328181 German. No abstract available.
Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
Bakris GL, Toto RD, McCullough PA. Bakris GL, et al. J Hum Hypertens. 2005 Feb;19(2):139-44. doi: 10.1038/sj.jhh.1001789. J Hum Hypertens. 2005. PMID: 15457206 Clinical Trial.
[Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
Luño J, Valderrábano F. Luño J, et al. An Med Interna. 1998 Nov;15(11):567-71. An Med Interna. 1998. PMID: 9882851 Review. Spanish. No abstract available.

See all similar articles

Cited by

Laboratory and clinical findings in mouse models of diabetic nephropathy induced with streptozotocin.
Wahono AM, Harnanik T, Pasaribu IA, Adiwinoto RP, Octavianda Y. Wahono AM, et al. BMC Endocr Disord. 2023 Nov 22;23(1):254. doi: 10.1186/s12902-023-01504-1. BMC Endocr Disord. 2023. PMID: 37990213 Free PMC article.
Effects of astragalosides from Radix Astragali on high glucose-induced proliferation and extracellular matrix accumulation in glomerular mesangial cells.
Chen X, Wang DD, Wei T, He SM, Zhang GY, Wei QL. Chen X, et al. Exp Ther Med. 2016 Jun;11(6):2561-2566. doi: 10.3892/etm.2016.3194. Epub 2016 Mar 24. Exp Ther Med. 2016. PMID: 27313676 Free PMC article.
ACTB Variants Confer the Genetic Susceptibility to Diabetic Kidney Disease in a Han Chinese Population.
Li M, Wu M, Qin Y, Zhou J, Su J, Pan E, Zhang Q, Zhang N, Sheng H, Dong J, Tong Y, Shen C. Li M, et al. Front Genet. 2019 Jul 23;10:663. doi: 10.3389/fgene.2019.00663. eCollection 2019. Front Genet. 2019. PMID: 31396261 Free PMC article.
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial.
Carrara F, Ruggenenti P, Perna A, Iliev IP, Gaspari F, Ferrari S, Stucchi N, Bossi A, Trevisan R, Remuzzi G, Parvanova A. Carrara F, et al. Acta Diabetol. 2022 Mar;59(3):309-317. doi: 10.1007/s00592-021-01804-9. Epub 2021 Oct 14. Acta Diabetol. 2022. PMID: 34648087 Clinical Trial.
Is the presence of retinopathy of practical value in defining cases of diabetic nephropathy in genetic association studies? The experience with the ACE insertion/deletion polymorphism in 53 studies comprising 17,791 subjects.
Ng DP, Tai BC, Lim XL. Ng DP, et al. Diabetes. 2008 Sep;57(9):2541-6. doi: 10.2337/db08-0581. Epub 2008 Jun 3. Diabetes. 2008. PMID: 18523141 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information